{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T18:00:19Z","timestamp":1783360819148,"version":"3.54.6"},"reference-count":109,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Growth retardation is a major obstacle to full rehabilitation of children with chronic renal failure (CRF). Several factors have been identified as contributors to impaired linear growth and they include protein and calorie malnutrition, metabolic acidosis, growth hormone resistance, anemia, and renal osteodystrophy. Although therapeutic interventions such as the use of recombinant human growth hormone, recombinant human erythropoietin, and calcitriol have made substantial contributions, the optimal therapeutic strategy remains to be defined. Indeed, growth failure persists in a substantial proportion of children with renal failure and those treated with maintenance dialysis. In addition, the increasing prevalence of adynamic lesions of renal osteodystrophy and its effect on growth have raised concern about the continued generalized use of calcitriol in children with CRF. Recent studies have shown the critical roles of parathyroid hormone\u2013related protein (PTHrP) and the PTH\/PTHrP receptor in the regulation of endochondral bone formation. The PTH\/PTHrP receptor mRNA expression has been shown to be down-regulated in kidney and growth plate cartilage of animals with renal failure. Differences in the severity of secondary hyperparathyroidism influence not only growth plate morphology but also the expression of selected markers of chondrocyte proliferation and differentiation in these animals. Such findings suggest potential molecular mechanisms by which cartilage and bone development may be disrupted in children with CRF, thereby contributing to diminished linear growth.<\/jats:p>","DOI":"10.1359\/jbmr.1999.14.10.1680","type":"journal-article","created":{"date-parts":[[2006,4,26]],"date-time":"2006-04-26T19:50:15Z","timestamp":1146081015000},"page":"1680-1690","source":"Crossref","is-referenced-by-count":71,"title":["Growth Retardation in Children with Chronic Renal Failure"],"prefix":"10.1093","volume":"14","author":[{"given":"Beatriz D.","family":"Kuizon","sequence":"first","affiliation":[{"name":"Department of Pediatrics, UCLA School of Medicine, Los Angeles, California, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro B.","family":"Salusky","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, UCLA School of Medicine, Los Angeles, California, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024020713344752100_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s004670050462","article-title":"Chronic renal insufficiency in children and adolescents: The 1996 annual report of NAPRTCS","volume":"12","author":"Fivush","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s004670050232","article-title":"Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study","volume":"11","author":"Warady","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1203\/00006450-199409000-00009","article-title":"Final height and its predictive factors after renal transplantation in childhood","volume":"36","author":"Hokken-Koelega","year":"1994","journal-title":"Pediatr Res"},{"key":"2024020713344752100_bib4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1126\/science.273.5275.663","article-title":"PTH\/PTHrP receptor in early development and Indian hedgehog-regulated bone growth","volume":"273","author":"Lanske","year":"1996","journal-title":"Science"},{"key":"2024020713344752100_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1126\/science.273.5275.613","article-title":"Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein","volume":"273","author":"Vortkamp","year":"1996","journal-title":"Science"},{"key":"2024020713344752100_bib6","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1083\/jcb.126.6.1611","article-title":"Parathyroid hormone-related peptide-deleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation","volume":"126","author":"Amizuka","year":"1994","journal-title":"J Cell Biol"},{"key":"2024020713344752100_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1101\/gad.8.3.277","article-title":"Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene","volume":"8","author":"Karaplis","year":"1994","journal-title":"Genes Dev"},{"key":"2024020713344752100_bib8","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1210\/endo.137.11.8895385","article-title":"Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development","volume":"137","author":"Lee","year":"1996","journal-title":"Endocrinology"},{"key":"2024020713344752100_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jemt.1070280606","article-title":"Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes","volume":"28","author":"Hunziker","year":"1994","journal-title":"Microsc Res Technique"},{"key":"2024020713344752100_bib10","first-page":"3","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Baron","year":"1993"},{"key":"2024020713344752100_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1113\/jphysiol.1989.sp017676","article-title":"Physiological mechanisms adopted by chondrocytes in regulating longitudinal bone growth in rats","volume":"414","author":"Hunziker","year":"1989","journal-title":"J Physiol (Lond)"},{"key":"2024020713344752100_bib12","first-page":"313","volume-title":"Disorders of Bone and Mineral Metabolism","author":"Howell","year":"1992"},{"key":"2024020713344752100_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/endo.134.1.8275957","article-title":"Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: In situ localization of its receptor and c-fos messenger ribonucleic acids","volume":"134","author":"Lee","year":"1994","journal-title":"Endocrinology"},{"key":"2024020713344752100_bib14","first-page":"3","volume-title":"Principles of Bone Biology","author":"Marks","year":"1996"},{"key":"2024020713344752100_bib15","doi-asserted-by":"crossref","first-page":"10240","DOI":"10.1073\/pnas.93.19.10240","article-title":"Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation","volume":"93","author":"Weir","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024020713344752100_bib16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM199609053351004","article-title":"Constituitively activated receptors for parathyroid hormone and parathyroid hormone related peptide in Jansen's metaphyseal chondrodysplasia","volume":"335","author":"Schipani","year":"1996","journal-title":"N Engl J Med"},{"key":"2024020713344752100_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.7701349","article-title":"A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia","volume":"268","author":"Schipani","year":"1995","journal-title":"Science"},{"key":"2024020713344752100_bib18","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1210\/endo.139.12.6522","article-title":"Inactivating mutation in the human parathyroid hormone receptor type I gene in Blomstrand Chondrodysplasia","volume":"139","author":"Karaplis","year":"1998","journal-title":"Endocrinology"},{"key":"2024020713344752100_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1172\/JCI2918","article-title":"Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia","volume":"102","author":"Jobert","year":"1998","journal-title":"J Clin Invest"},{"key":"2024020713344752100_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/bmj.2.5912.189","article-title":"Growth pattern and dietary intake of children with chronic renal insufficiency","volume":"2","author":"Betts","year":"1974","journal-title":"Br Med J"},{"key":"2024020713344752100_bib21","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0022-3476(05)82925-7","article-title":"Linear growth and anthropometric and nutritional measurements in children with mild to moderate renal insufficiency: A report of the Growth Failure in Children with Renal Diseases Study","volume":"116","author":"Abitbol","year":"1990","journal-title":"J Pediatr"},{"key":"2024020713344752100_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000181399","article-title":"Growth in renal failure","volume":"21","author":"Mehls","year":"1978","journal-title":"Nephron"},{"key":"2024020713344752100_bib23","first-page":"1241","volume-title":"Pediatric Nephrology","author":"Schaefer","year":"1994"},{"key":"2024020713344752100_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM197109162851203","article-title":"Relation of caloric deficiency to growth failure in children on hemodialysis and the growth response to caloric supplementation","volume":"285","author":"Simmons","year":"1971","journal-title":"N Engl J Med"},{"key":"2024020713344752100_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/bmj.1.6058.416","article-title":"Role of dietary energy supplementation in growth of children with chronic renal insufficiency","volume":"1","author":"Betts","year":"1977","journal-title":"Br Med J"},{"key":"2024020713344752100_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ki.1983.145","article-title":"Effects of calorie supplementation on growth in children with uremia","volume":"24","author":"Arnold","year":"1983","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ki.1984.133","article-title":"Growth in children with chronic renal failure on conservative treatment","volume":"26","author":"Rizzoni","year":"1984","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib28","first-page":"306","article-title":"Tube feeding in children with end-stage renal disease","volume":"23","author":"Kuizon","year":"1997","journal-title":"Miner Electrolyte Metab"},{"key":"2024020713344752100_bib29","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0140-6736(96)09260-4","article-title":"Randomized multicenter study of a low-protein diet on the progression of chronic renal failure in children. European study group of nutritional treatment of chronic renal failure in childhood","volume":"349","author":"Wingen","year":"1997","journal-title":"Lancet"},{"key":"2024020713344752100_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/adc.68.3.371","article-title":"Protein restriction in chronic renal failure","volume":"68","author":"Kist-van Holthe tot Echten","year":"1993","journal-title":"Arch Dis Child"},{"key":"2024020713344752100_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00868260","article-title":"Dietary protein and growth in infants with chronic renal insufficiency: A report from the Southwest Pediatric Nephrology Study Group and the University of California, San Francisco","volume":"8","author":"Uauy","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI108962","article-title":"Attainment and maintenance of normal status with alkali therapy in infants and children with classic renal tubular acidosis (RTA)","volume":"61","author":"McSherry","year":"1978","journal-title":"J Clin Invest"},{"key":"2024020713344752100_bib33","first-page":"535A","article-title":"The effect of acidosis on human growth hormone release with non-azotemic renal tubular acidosis","volume":"28","author":"McSherry","year":"1980","journal-title":"Clin Res"},{"key":"2024020713344752100_bib34","first-page":"E547","article-title":"Metabolic acidosis inhibits growth hormone secretion in rats: Mechanism of growth retardation","volume":"265","author":"Challa","year":"1993","journal-title":"Am J Physiol"},{"key":"2024020713344752100_bib35","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/ki.1993.372","article-title":"Effect of metabolic acidosis on the expression of insulin-like growth factor and growth hormone receptor","volume":"44","author":"Challa","year":"1993","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib36","first-page":"363A","article-title":"Insulin-like growth factor-1 gene expression in the tibial epiphyseal growth plate of the acidotic and nutritionally limited rat","volume":"37","author":"Hanna","year":"1995","journal-title":"Pediatr Res"},{"key":"2024020713344752100_bib37","first-page":"354A","article-title":"Discordant effects of recombinant human growth hormone (rhGH) on bone, kidney, and linear growth in acidotic adult (A) and weanling (W) rats","volume":"33","author":"Chobanian","year":"1993","journal-title":"Pediatr Res"},{"key":"2024020713344752100_bib38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ki.1997.26","article-title":"Effect of chronic metabolic acidosis on the growth hormone\/IGF-1 endocrine axis: New cause of growth hormone insensitivity in humans","volume":"51","author":"Brungger","year":"1997","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib39","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/ki.1994.145","article-title":"Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia","volume":"45","author":"Tonshoff","year":"1994","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib40","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1210\/jcem.82.4.3893","article-title":"Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: Correlation with GH insensitivity","volume":"82","author":"Tonshoff","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713344752100_bib41","first-page":"S106","article-title":"Derangements of the somatotropic hormone axis in chronic renal failure","volume":"51","author":"Tonshoff","year":"1997","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib42","first-page":"2978","article-title":"Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure: A report of the Southwest Pediatric Nephrology Study Group","volume":"82","author":"Powell","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713344752100_bib43","first-page":"1654","article-title":"The insulin-like growth factor axis and growth in children with chronic renal failure: A report of the Southwest Pediatric Nephrology Study Group","volume":"83","author":"Powell","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713344752100_bib44","first-page":"42","article-title":"Pediatric uses of recombinant human erythropoietin: The outlook in 1991","volume":"18","author":"Alexander","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"2024020713344752100_bib45","first-page":"26","article-title":"Exercise tolerance in end-stage renal disease","volume":"10","author":"Zanconato","year":"1990","journal-title":"Child Nephrol Urol"},{"key":"2024020713344752100_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1651-2227.1978.tb16275.x","article-title":"Cardiovascular impairment and physical working capacity in children with chronic renal failure","volume":"67","author":"Ulmer","year":"1978","journal-title":"Acta Paediatr Scand"},{"key":"2024020713344752100_bib47","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(86)92192-6","article-title":"Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis","volume":"2","author":"Winearls","year":"1986","journal-title":"Lancet"},{"key":"2024020713344752100_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial","volume":"316","author":"Eschbach","year":"1987","journal-title":"N Engl J Med"},{"key":"2024020713344752100_bib49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0022-3476(89)80692-4","article-title":"Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis","volume":"114","author":"Sinai-Trieman","year":"1989","journal-title":"J Pediatr"},{"key":"2024020713344752100_bib50","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/BF00858637","article-title":"Recombinant human erythropoietin therapy in children maintained by hemodialysis","volume":"4","author":"Rigden","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib51","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0022-3476(05)80688-2","article-title":"Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis","volume":"117","author":"Montini","year":"1990","journal-title":"J Pediatr"},{"key":"2024020713344752100_bib52","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/adc.69.5.580","article-title":"Non-cardiac benefits of human recombinant erythropoietin in end stage renal failure and anaemia","volume":"69","author":"Morris","year":"1993","journal-title":"Arch Dis Child"},{"key":"2024020713344752100_bib53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF00866354","article-title":"A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis","volume":"8","author":"Van Damme-Lombaerts","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib54","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/BF00857883","article-title":"Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis","volume":"5","author":"Warady","year":"1991","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib55","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0031-3955(16)40098-2","article-title":"New hormones in the therapeutic arsenal of chronic renal failure","volume":"42","author":"Warady","year":"1995","journal-title":"Pediatr Clin North Am"},{"key":"2024020713344752100_bib56","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/adc.45.242.502","article-title":"Growth of children with thalassaemia: Effect of different transfusion regimens","volume":"45","author":"Kattamis","year":"1970","journal-title":"Arch Dis Child"},{"key":"2024020713344752100_bib57","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0022-3476(80)80557-9","article-title":"Pre- and postnatal growth and development in sickle cell anemia","volume":"96","author":"Kramer","year":"1980","journal-title":"J Pediatr"},{"key":"2024020713344752100_bib58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/BF00866771","article-title":"The effects of recombinant human erythropoietin on growth and nutritional status","volume":"10","author":"Jabs","year":"1996","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib59","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/BF01453701","article-title":"The influence of steroid therapy and recombinant human erythropoietin on the growth of children with renal disease","volume":"5","author":"Rees","year":"1991","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib60","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1651-2227.1993.tb12607.x","article-title":"Treatment of renal anemia by subcutaneous erythropoietin in children with preterminal chronic renal failure","volume":"82","author":"Scharer","year":"1993","journal-title":"Acta Paediatr"},{"key":"2024020713344752100_bib61","first-page":"227","volume-title":"Endstage Renal Disease in Children","author":"Mehls","year":"1984"},{"key":"2024020713344752100_bib62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/ki.1995.335","article-title":"Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy","volume":"48","author":"Salusky","year":"1995","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib63","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.1988.96","article-title":"Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD","volume":"33","author":"Salusky","year":"1988","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1210\/jcem-39-1-119","article-title":"Quantitative histological studies on the pathogenesis of uremic bone disease","volume":"39","author":"Sherrard","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713344752100_bib65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ki.1990.187","article-title":"Renal bone disease 1990: An unmet challenge for the nephrologist","volume":"38","author":"Malluche","year":"1990","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib66","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1681\/ASN.V3121938","article-title":"Renal bone disease in pediatric patients and young adults treated by hemodialysis in a childrens hospital","volume":"12","author":"Mathias","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"2024020713344752100_bib67","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure: An evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib68","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib69","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1993.323","article-title":"Aplastic osteodystrophy without aluminum: The role of \u2018suppressed\u2019 parathyroid function","volume":"44","author":"Hercz","year":"1993","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ndt\/9.5.517","article-title":"Adynamic bone disease with negative aluminum staining in predialysis patients: Prevalence and evolution after maintenance dialysis","volume":"9","author":"Hernandez","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"2024020713344752100_bib71","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.1998.00045.x","article-title":"Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration","volume":"54","author":"Salusky","year":"1998","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib72","first-page":"304","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Goodman","year":"1996"},{"key":"2024020713344752100_bib73","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1046\/j.1523-1755.1998.00199.x","article-title":"Growth of long bones in renal failure: Roles of hyperparathyroidism, growth hormone and calcitriol","volume":"54","author":"Sanchez","year":"1998","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib74","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-3476(89)80833-9","article-title":"Accelerated growth after recombinant human growth hormone treatment in children with chronic renal failure","volume":"115","author":"Koch","year":"1989","journal-title":"J Pediatr"},{"key":"2024020713344752100_bib75","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0022-3476(94)70358-2","article-title":"Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled study","volume":"124","author":"Fine","year":"1994","journal-title":"J Pediatr"},{"key":"2024020713344752100_bib76","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(05)81603-8","article-title":"Growth-stimulation effects of recombinant human growth hormone in children with end-stage renal disease","volume":"116","author":"Tonshoff","year":"1990","journal-title":"J Pediatr"},{"key":"2024020713344752100_bib77","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJM197802022980503","article-title":"Increased growth after long-term oral 1,25-vitamin D3 in childhood renal osteodystrophy","volume":"298","author":"Chesney","year":"1978","journal-title":"N Engl J Med"},{"key":"2024020713344752100_bib78","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1001\/jama.1977.03280200065024","article-title":"Growth velocity in a child on prolonged hemodialysis: Beneficial effect of 1-alpha-hydroxyvitamin D3","volume":"238","author":"Chan","year":"1977","journal-title":"JAMA"},{"key":"2024020713344752100_bib79","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1542\/peds.68.4.559","article-title":"Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure","volume":"68","author":"Chan","year":"1981","journal-title":"Pediatrics"},{"key":"2024020713344752100_bib80","first-page":"192","article-title":"Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol","volume":"24","author":"Hodson","year":"1985","journal-title":"Clin Nephrol"},{"key":"2024020713344752100_bib81","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0022-3476(05)83128-2","article-title":"A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol","volume":"124","author":"Chan","year":"1994","journal-title":"J Pediatr"},{"key":"2024020713344752100_bib82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.1987.176","article-title":"\u2018High-dose\u2019 calcitriol for control of renal osteodystrophy in children on CAPD","volume":"32","author":"Salusky","year":"1987","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib83","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1523-1755.1998.00724.x","article-title":"Diminished linear growth during treatment with intermittent calcitriol and dialysis in children with chronic renal failure","volume":"53","author":"Kuizon","year":"1998","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000420142","article-title":"Evolution of secondary hyperparathyroidism during daily oral calcitriol therapy in pediatric renal osteodystrophy","volume":"90","author":"Goodman","year":"1991","journal-title":"Contrib Nephrol"},{"key":"2024020713344752100_bib85","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0272-6386(12)80832-8","article-title":"Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: Preliminary observations","volume":"19","author":"Martin","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"2024020713344752100_bib86","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"N Engl J Med"},{"key":"2024020713344752100_bib87","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J Clin Invest"},{"key":"2024020713344752100_bib88","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib89","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/BF00860951","article-title":"Calcitriol oral pulse therapy in children with renal osteodystrophy","volume":"9","author":"Cano","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib90","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02556257","article-title":"1,25(OH)2D3 receptor regulation and 1,25(OH)2D3 effects in primary cultures of growth cartilage cells of the rat","volume":"49","author":"Klaus","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"2024020713344752100_bib91","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF01453682","article-title":"Effect of vitamin D on growth cartilage cell proliferation in vitro","volume":"5","author":"Klaus","year":"1991","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib92","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium \u00d7 phosphorus product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"2024020713344752100_bib93","first-page":"549A","article-title":"Changes in growth plate morphology in a rat model of adynamic bone","volume":"9","author":"Sanchez","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2024020713344752100_bib94","first-page":"53","article-title":"Skeletal growth in experimental uremia","volume":"24","author":"Mehls","year":"1983","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib95","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ki.1988.7","article-title":"Improvement of growth and food utilization by recombinant human growth hormone in uremia","volume":"33","author":"Mehls","year":"1988","journal-title":"Kidney Int"},{"key":"2024020713344752100_bib96","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1111\/j.1651-2227.1988.tb10812.x","article-title":"Accelerated growth following recombinant human growth hormone (rhGH) in children with chronic renal failure","volume":"343","author":"Lippe","year":"1988","journal-title":"Acta Paediatr Scand Suppl"},{"key":"2024020713344752100_bib97","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/adc.65.8.856","article-title":"Treatment of short stature in renal disease with recombinant human growth hormone","volume":"65","author":"Rees","year":"1990","journal-title":"Arch Dis Child"},{"key":"2024020713344752100_bib98","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1651-2227.1990.tb11668.x","article-title":"Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: An interim report on five European studies","volume":"370","author":"Johansson","year":"1990","journal-title":"Acta Paediatr Scand Suppl"},{"key":"2024020713344752100_bib99","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00874012","article-title":"Accelerated growth in short children with chronic renal failure treated with both strict dietary therapy and recombinant growth hormone","volume":"6","author":"van Renen","year":"1992","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF01957731","article-title":"Growth hormone treatment in children with preterminal chronic renal failure: No adverse effect on glomerular filtration rate","volume":"151","author":"Tonshoff","year":"1992","journal-title":"Eur J Pediatr"},{"key":"2024020713344752100_bib101","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0140-6736(91)90604-N","article-title":"Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure","volume":"338","author":"Hokken-Koelega","year":"1991","journal-title":"Lancet"},{"key":"2024020713344752100_bib102","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1651-2227.1991.tb12041.x","article-title":"Effects of two years of growth hormone treatment in short children with renal disease","volume":"379","author":"Tonshoff","year":"1991","journal-title":"Acta Paediatr Scand Suppl"},{"key":"2024020713344752100_bib103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1651-2227.1991.tb12042.x","article-title":"Growth hormone treatment in short children with chronic renal failure and after renal transplantation: Combined data from European clinical trials","volume":"379","author":"Van Es","year":"1991","journal-title":"Acta Paediatr Scand Suppl"},{"key":"2024020713344752100_bib104","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s004670050459","article-title":"Recombinant human growth hormone treatment of children on hemodialysis","volume":"12","author":"Berard","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF00866763","article-title":"Short dialyzed children respond less to growth hormone than patients prior to dialysis","volume":"10","author":"Wuhl","year":"1996","journal-title":"Pediatr Nephrol"},{"key":"2024020713344752100_bib106","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00312829","article-title":"Evidence for a direct effect of growth hormone on osteoblasts","volume":"273","author":"Morel","year":"1993","journal-title":"Cell Tissue Res"},{"key":"2024020713344752100_bib107","first-page":"309","article-title":"Treatment of adults with growth hormone (GH) deficiency with recombinant human GH","volume":"76","author":"Bengtsson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713344752100_bib108","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/endo-125-3-1239","article-title":"Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells","volume":"125","author":"Maor","year":"1989","journal-title":"Endocrinology"},{"key":"2024020713344752100_bib109","first-page":"546A","article-title":"Effects of growth hormone on bone and mineral metabolism in dialyzed children","volume":"9","author":"Kuizon","year":"1998","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.1999.14.10.1680","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/14\/10\/1680\/56599976\/5650141005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/14\/10\/1680\/56599976\/5650141005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:57:19Z","timestamp":1710341839000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/14\/10\/1680-1690\/7514812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10,1]]},"references-count":109,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[1999,10,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.1999.14.10.1680","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,10,1]]},"published":{"date-parts":[[1999,10,1]]}}}